Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
about
Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancerAdditional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patientsAnti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery systemA clinical trial on efficacy and safety of teicoplanin in combination with beta-lactams and aminoglycosides in the treatment of severe sepsis of patients undergoing allogeneic/autologous bone marrow transplantation.Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureusEffects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patientsVancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patientsEmpirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.A survey of the use of teicoplanin in patients with haematological malignancies and solid tumours.Therapeutic update on glycopeptide and lipopeptide antibiotics.Pharmacokinetics of teicoplanin in pediatric patients.Evaluation of a novel fluorescence polarization immunoassay for teicoplaninTeicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.Patterns of infection in 41 patients with idiosyncratic drug-induced agranulocytosis.Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients.Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.Options and limitations of teicoplanin in febrile granulocytopenic patients.
P2860
Q24201136-ED3E4FA8-2761-4037-9D77-BF1666B8E331Q24246468-A744BFEB-A0B3-44CC-A418-4CD665CC976FQ28468292-B5800A4F-6EC4-46BF-8AD7-AE70235D85C3Q33394903-FE1AC782-49A6-40D3-AA81-F6FD743A4E4CQ33756241-CB361EE8-DD5A-4608-A2E8-51EF53F294CDQ33758447-973E5D8E-2DC8-46A0-AF01-67DD721499EFQ35271608-308A9DA1-59B8-4178-9301-9BD965B1323CQ35836302-393E8E60-BA92-488E-8BD8-EE1D0A2129E9Q36752580-61CB8843-D75F-4945-95B3-7740F1275F60Q36753331-E0CAB097-38E6-40DB-87C0-CE5AFD0ACADBQ38747206-8C7DF1B4-E3D3-429F-8CBC-FEDC559F7EA1Q39235645-8D0C7E6B-3F73-43B3-B6BB-AEA3E317E0F3Q39291062-CF350416-563E-4101-A03D-7C423F6D96BEQ39818673-74A3B8DD-C221-46AF-BAAB-2630ED323E9CQ39866638-C483C829-1F57-44D5-97BB-1797D7D7D3CCQ40733574-D0CEDEE0-105C-419F-8A5B-D0980BC6B012Q40745985-E7D8A5FB-D3C3-407C-AF02-CCE8E677F32EQ40755944-010280B0-8E81-4A29-859D-456818998B42Q40755952-3B7A5F9D-191D-4102-967E-85FC51C95899Q40755958-0A0E1E4E-C0D5-4FF9-8C0E-A79C9ABC1D5AQ40755988-1701546B-112C-4902-9D6B-8073CC70405DQ40755994-5B25573E-F68A-4A68-8F08-7AA7E0886C5CQ40756002-C96A1CFB-13C1-4708-93B8-82D8896B6BB4
P2860
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Prospective randomized clinica ...... penic acute leukemia patients.
@en
Prospective randomized clinica ...... penic acute leukemia patients.
@nl
type
label
Prospective randomized clinica ...... penic acute leukemia patients.
@en
Prospective randomized clinica ...... penic acute leukemia patients.
@nl
prefLabel
Prospective randomized clinica ...... penic acute leukemia patients.
@en
Prospective randomized clinica ...... penic acute leukemia patients.
@nl
P2093
P2860
P356
P1476
Prospective randomized clinica ...... openic acute leukemia patients
@en
P2093
A Del Favero
F Baldelli
F Menichetti
G Bucaneve
R Guerciolini
S Pauluzzi
P2860
P304
P356
10.1128/AAC.31.7.1126
P407
P577
1987-07-01T00:00:00Z